Observational studyJournal of epidemiology and global health2025
Association Between Maternal Creatinine to Body Weight Ratio and Small/Large for Gestational Age Newborns Among 11,734 Chinese Women.
Observational study in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Establishing a reference range for serum creatinine in the neonatal population and re-defining neonatal acute kidney injury.Pediatric nephrology (Berlin, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSerum creatinine to body weight ratio (CBWR) is closely associated with non-alcoholic fatty liver disease, diabetes, and all-cause mortality. This study aimed to assess the impact of CBWR in late pregnancy on incident small and large for gestational age (SGA/LGA) deliveries.
methodsThis observational study included 11,734 pregnant women with hospital-based hepatic/renal data (2016-2017). Demographic characteristics were compared between CBWR quintiles using appropriate parametric or nonparametric tests. Relationship between CBWR and clinical/laboratory parameters was assessed using Spearman's correlation. Linear regression was employed to evaluate the association of CBWR with fetal birth length/weight, while logistic regression was used to calculate adjusted odds ratios (ORs) for SGA/LGA, with both models adjusting for maternal age, parity, blood pressure, gestational week, assisted reproduction, neonatal sex, and laboratory results. Sensitivity analyses and subgroup stratifications confirmed these associations. Non-linear trends were explored using smooth curve fitting techniques.
resultsAmong these newborns, 1033 (8.80%) were classified as SGA and 1,827 (15.57%) as LGA. CBWR was associated with smaller birth length (β = -0.21 cm; 95% CI: -0.28, -0.15) and lower birth weight (β = -0.29 kg; 95% CI: -0.31, -0.27) in the highest versus lowest quintile. The multivariate-adjusted ORs of SGA in higher quintiles versus the lowest quintile of CBWR were 1.63 (95% CI: 1.21, 2.21), 2.16 (95% CI: 1.61, 2.89), 2.99 (95% CI: 2.25, 3.97), and 5.24 (95% CI: 3.97, 6.92), respectively; those for LGA were 0.60 (95% CI: 0.52, 0.70), 0.53 (95% CI: 0.46, 0.62), 0.39 (95% CI: 0.32, 0.46), and 0.23 (95% CI: 0.19, 0.29), respectively. Per standard deviation (SD) increase in CBWR was accompanied by a 1.63-fold increase in SGA risk (OR = 1.63, 95% CI: 1.52, 1.75) and a 42% decrease in LGA risk (OR = 0.58, 95% CI: 0.55, 0.63). Sensitivity analysis confirmed the consistence of these findings. Subgroup analysis demonstrated that CBWR was strongly associated with SGA risk in women with CBWR > 0.98 umol/L/kg complicated by preeclampsia or preterm birth, while in those complicated by gestational diabetes mellitus, the association was attenuated.
conclusionOur findings suggest that elevated CBWR in late pregnancy may be associated with decreased LGA risk and increased SGA risk. While CBWR represents an easily measurable and cost-effective potential indicator, these observational results require validation in prospective, population-based studies before considering clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.